SOHO Italy

www.sohoitaly.it

 

SOHO Italy 2022 on the Phase 2/3 HARBOR Study: BLU-263 in Patients With Indolent Systemic Mastocytosis and Monoclonal Mast Cell Activation Syndrome

0 views
December 1, 2022
Comments 0
Login to view comments. Click here to Login